Hudson Bay Capital Management
ICCM icon

Hudson Bay Capital Management’s IceCure Medical ICCM Stock Holding History

Hudson Bay Capital Management’s Portfolio ICCM Stock Details ICCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.03K Buy
+1,000
New +$18.3K ﹤0.01% 1359

Other funds holding ICCM

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gunderson Capital Management Mt. Pleasant, South Carolina $370M AUM 211.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KFG
Kingdom Financial Group Peoria, Arizona $349M AUM 12.25% 1-Year Est. Return
LAS
Lloyd Advisory Services Suwanee, Georgia $349M AUM 13.97% 1-Year Est. Return

Hudson Bay Capital Management's ICCM Position: Q1 2026 in Review

Hudson Bay Capital Management opened a new position in IceCure Medical (ICCM) in Q1 2026: 1,000 shares worth $9.03K. The stake represents ﹤0.01% of the portfolio and ranks #1359 among its holdings.

17 funds tracked by Wall St. Rank hold ICCM as of Q1 2026.

  • Hudson Bay Capital Management held 1,000 shares of IceCure Medical worth $9.03K as of Q1 2026.
  • IceCure Medical was a new Hudson Bay Capital Management position in Q1 2026.
  • IceCure Medical made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #1359 holding.
  • 17 funds tracked by Wall St. Rank held IceCure Medical as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.